Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.
2.

Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data.

Gail MH, You WC, Chang YS, Zhang L, Blot WJ, Brown LM, Groves FD, Heinrich JP, Hu J, Jin ML, Li JY, Liu WD, Ma JL, Mark SD, Rabkin CS, Fraumeni JF Jr, Xu GW.

Control Clin Trials. 1998 Aug;19(4):352-69.

PMID:
9683311
3.

Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.

You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS, Ma JL, Pan KF, Liu WD, Hu Y, Crystal-Mansour S, Pee D, Blot WJ, Fraumeni JF Jr, Xu GW, Gail MH.

J Natl Cancer Inst. 2006 Jul 19;98(14):974-83.

PMID:
16849680
4.

An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity.

You WC, Chang YS, Heinrich J, Ma JL, Liu WD, Zhang L, Brown LM, Yang CS, Gail MH, Fraumeni JF Jr, Xu GW.

Eur J Cancer Prev. 2001 Jun;10(3):257-63.

PMID:
11432713
5.
6.

Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality.

Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, Liu WD, Hu Y, Han ZX, Crystal-Mansour S, Pee D, Blot WJ, Fraumeni JF Jr, You WC, Gail MH.

J Natl Cancer Inst. 2012 Mar 21;104(6):488-92. doi: 10.1093/jnci/djs003. Epub 2012 Jan 23.

7.

Helicobacter pylori infection, garlic intake and precancerous lesions in a Chinese population at low risk of gastric cancer.

You WC, Zhang L, Gail MH, Ma JL, Chang YS, Blot WJ, Li JY, Zhao CL, Liu WD, Li HQ, Hu YR, Bravo JC, Correa P, Xu GW, Fraumeni JF Jr.

Int J Epidemiol. 1998 Dec;27(6):941-4.

PMID:
10024185
8.

Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.

Wong BC, Zhang L, Ma JL, Pan KF, Li JY, Shen L, Liu WD, Feng GS, Zhang XD, Li J, Lu AP, Xia HH, Lam S, You WC.

Gut. 2012 Jun;61(6):812-8. doi: 10.1136/gutjnl-2011-300154. Epub 2011 Sep 13.

PMID:
21917649
9.

Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data.

Muñoz N, Vivas J, Buiatti E, Kato I, Oliver W.

IARC Sci Publ. 1996;(139):125-33.

PMID:
8923024
10.

Re: Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.

Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, Correa P.

J Natl Cancer Inst. 2006 Oct 4;98(19):1426. No abstract available.

PMID:
17018791
11.

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS; China Gastric Cancer Study Group.

JAMA. 2004 Jan 14;291(2):187-94.

PMID:
14722144
12.

Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population.

Plummer M, Vivas J, Lopez G, Bravo JC, Peraza S, Carillo E, Cano E, Castro D, Andrade O, Sánchez V, Garcia R, Buiatti E, Aebischer C, Franceschi S, Oliver W, Muñoz N.

J Natl Cancer Inst. 2007 Jan 17;99(2):137-46.

PMID:
17227997
13.

[Preliminary report on the results of nutrition prevention trials of cancer and other common diseases among residents in Linxian, China].

Li JY, Li B, Blot WJ, Taylor PR.

Zhonghua Zhong Liu Za Zhi. 1993 May;15(3):165-81. Chinese.

PMID:
8261860
14.

Long-term garlic or micronutrient supplementation, but not anti-Helicobacter pylori therapy, increases serum folate or glutathione without affecting serum vitamin B-12 or homocysteine in a rural Chinese population.

Wang Y, Zhang L, Moslehi R, Ma J, Pan K, Zhou T, Liu W, Brown LM, Hu Y, Pee D, Gail MH, You W.

J Nutr. 2009 Jan;139(1):106-12. doi: 10.3945/jn.108.091389. Epub 2008 Dec 3.

15.

Manganese superoxide dismutase polymorphism and risk of gastric lesions, and its effects on chemoprevention in a Chinese population.

Tu HK, Pan KF, Zhang Y, Li WQ, Zhang L, Ma JL, Li JY, You WC.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1089-97. doi: 10.1158/1055-9965.EPI-09-1174. Epub 2010 Mar 16.

16.

Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial in Linxian, China.

Wang GQ, Dawsey SM, Li JY, Taylor PR, Li B, Blot WJ, Weinstein WM, Liu FS, Lewin KJ, Wang H, et al.

Cancer Epidemiol Biomarkers Prev. 1994 Mar;3(2):161-6.

17.

Etiology and prevention of gastric cancer: a population study in a high risk area of China.

You WC, Li JY, Zhang L, Jin ML, Chang YS, Ma JL, Pan KF.

Chin J Dig Dis. 2005;6(4):149-54.

PMID:
16246221
18.

Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China. Linxian Nutrition Intervention Trials Study Group.

Taylor PR, Li B, Dawsey SM, Li JY, Yang CS, Guo W, Blot WJ.

Cancer Res. 1994 Apr 1;54(7 Suppl):2029s-2031s.

19.

Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?

Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, Grilli D, Bazzoli F.

Ann Intern Med. 2009 Jul 21;151(2):121-8. Erratum in: Ann Intern Med. 2009 Oct 6;151(7):516.

PMID:
19620164
20.

Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the Dysplasia Trial in Linxian, China.

Dawsey SM, Wang GQ, Taylor PR, Li JY, Blot WJ, Li B, Lewin KJ, Liu FS, Weinstein WM, Wiggett S, et al.

Cancer Epidemiol Biomarkers Prev. 1994 Mar;3(2):167-72.

Supplemental Content

Support Center